FDA Approved: AXTLE — Supplemental Application (Avyxa Pharma, LLC)

View source ↗

Summary

FDA approved a supplemental application for AXTLE (pemetrexed) submitted by Avyxa Pharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma
• Non-small Cell Lung Cancer

Drugs mentioned

• AXTLE (PEMETREXED)

Snippet

SUPPL AP for AXTLE (PEMETREXED)